QUETIAPINE

20 Mg/Ml Oral Suspension

Rosemont Pharmaceuticals LtdPA0312/028/005

Main Information

Trade NameQUETIAPINE
Active SubstancesQUETIAPINE FUMARATE
Strength20 Mg/Ml
Dosage FormOral Suspension
Licence HolderRosemont Pharmaceuticals Ltd
Licence NumberPA0312/028/005

Group Information

ATC CodeN05AH04 Antipsychotics

Status

Authorised/WithdrawnAuthorised
Licence Issued08/07/2016
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing Status--Unknown--
Promotion StatusPromotion to Healthcare Professionals only
Conditions of Licence

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.